Khushi Vishal Kalavadia is a Urbana, Illinois based nurse practitioner. Active license number of Khushi Vishal Kalavadia is 209032334 for Acute Care in Illinois. Her current practice location is 611 W Park St, Urbana. Patients can reach her at 217-383-3129 and her NPI number (Unique professional ID assigned by NPPES) is 1063223931. Khushi Vishal Kalavadia has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Khushi Vishal Kalavadia speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1063223931
NPI Enumeration Date:
18 Jan, 2025
NPI Last Update On:
24 Jul, 2025
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Khushi Vishal Kalavadia are as mentioned below.
License Number
Specialization
State
Status
209032334
Acute Care
Illinois
Primary
041531458
Registered Nurse
Illinois
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Khushi Vishal Kalavadia 611 W Park St, Fapc Urbana, Illinois
Zip:
61801-2501
Patients can reach Khushi Vishal Kalavadia at 611 W Park St, Urbana, Illinois or can call to book an appointment on 217-383-3129.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 October, 2025.